Acute symptomatic seizures secondary to myelin oligodendrocyte glycoprotein antibody-associated disease.
ADEM
MOG
MOGAD
UCE
autoimmune epilepsy
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
25
09
2022
received:
06
05
2022
accepted:
26
09
2022
pubmed:
29
9
2022
medline:
15
12
2022
entrez:
28
9
2022
Statut:
ppublish
Résumé
To report the clinical presentations and outcomes of patients with seizure and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). We retrospectively reviewed the electronic medical records for clinical and paraclinical features among patients with seizures and MOG-IgG (immunoglobulin G) seropositivity. We identified 213 patients with MOG-IgG seropositivity who fulfilled criteria for MOGAD. Seizures attributed to central nervous system (CNS) autoimmunity were observed in 10% of patients (n = 23: 19 children, 4 adults). The majority (n = 19, 83%) had pediatric disease onset. Focal motor seizures were the most common seizure semiology (16/23; 70%). Focal to bilateral tonic-clonic seizures were present in 12 patients (53%), and 3 patients (13%) developed status epilepticus. All patients had features of encephalitis at onset of seizures. Cerebral cortical encephalitis (CCE) was the most common radiological finding (10 unilateral and 5 bilateral cases). Eight of 23 patients (35%) had only CCE, six of 23 patients (26%) had only acute disseminated encephalomyelitis (ADEM), and seven of 23 patients (30%) had features of both. Fifteen patients (65%) had leptomeningeal enhancement. Three patients (13%) had coexistence of N-methyl-d-aspartate receptor (NMDAR) IgG. Only 3 of 23 patients (13%) developed drug- resistant epilepsy. Although the majority had MOGAD relapses (14/23, 60%) had only 5 of 23 patients had recurrence of episodes of encephalitis with associated seizures. Twenty-one of 23 patients (91%) had seizure freedom at last follow-up. MOG-IgG evaluation should be considered in patients who present with encephalitis and focal motor and/or focal to bilateral tonic-clonic seizures, especially pediatric patients with magnetic resonance imaging (MRI) brain findings consistent with CCE, ADEM, or other MOGAD presentations. The majority of these seizures are self-limited and do not require maintenance/chronic antiseizure medications. Although seizure recurrence is uncommon, many patients have MOGAD relapses in the form of encephalitis and optic neuritis.
Identifiants
pubmed: 36168809
doi: 10.1111/epi.17424
pmc: PMC10641900
mid: NIHMS1935946
doi:
Substances chimiques
Myelin-Oligodendrocyte Glycoprotein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3180-3191Subventions
Organisme : NINDS NIH HHS
ID : R01 NS113828
Pays : United States
Informations de copyright
© 2022 International League Against Epilepsy.
Références
Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e163
pubmed: 26516628
Clin Chem. 2020 Dec 1;66(12):1496-1509
pubmed: 33221892
Neurology. 2021 Sep 28;97(13):e1351-e1358
pubmed: 34389648
Lancet Neurol. 2020 Mar;19(3):234-246
pubmed: 32057303
Neurology. 2019 Mar 12;92(11):e1250-e1255
pubmed: 30728305
Rinsho Shinkeigaku. 2017 Nov 25;57(11):723-728
pubmed: 29070756
Nat Rev Neurol. 2013 Aug;9(8):455-61
pubmed: 23797245
Neurology. 2021 Sep 14;97(11):e1141-e1149
pubmed: 34233939
JAMA Neurol. 2018 Jan 1;75(1):65-71
pubmed: 29131884
JAMA Neurol. 2018 Nov 1;75(11):1355-1363
pubmed: 30014148
Epilepsia. 2022 Mar;63(3):709-722
pubmed: 35032032
J Neuroinflammation. 2018 May 3;15(1):134
pubmed: 29724224
Neuropsychol Rev. 2007 Dec;17(4):413-25
pubmed: 17943448
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-137
pubmed: 29142145
J Neurol Sci. 2018 Sep 15;392:113-115
pubmed: 30048831
Mayo Clin Proc. 2022 Mar;97(3):547-559
pubmed: 34955239
Epilepsia. 2020 Jul;61(7):1341-1351
pubmed: 32544279
JAMA Neurol. 2020 May 1;77(5):648-649
pubmed: 32119057
Neurol Neuroimmunol Neuroinflamm. 2022 Mar 25;9(3):
pubmed: 35338092
Neurol Neuroimmunol Neuroinflamm. 2017 Jan 16;4(2):e322
pubmed: 28105459
Mult Scler. 2021 Jul;27(8):1175-1186
pubmed: 32907470
Mult Scler Relat Disord. 2017 Nov;18:90-92
pubmed: 29141829
Epilepsia. 2017 Dec;58(12):2104-2111
pubmed: 29098690
JAMA Neurol. 2021 Jun 1;78(6):741-746
pubmed: 33900394
J Neurol Sci. 2018 Apr 15;387:170-173
pubmed: 29571858
Eur J Radiol. 2013 Nov;82(11):1964-72
pubmed: 23787273
Curr Opin Neurol. 2020 Jun;33(3):372-380
pubmed: 32374573
Mult Scler Relat Disord. 2020 Jun;41:102011
pubmed: 32163756